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Abstract
Blood specimens are labeled at the time of acquisition in order to identify and match the
specimen, label, and order to the patient. While the labeling process is not new, it is frequently
laden with errors (Brown, Smith, & Sherfy, 2011). Wrong blood in tube (WBIT) poses
significant risk. Multiple factors contribute to mislabeling errors, including lax policies, limited
technological solutions, decentralized labeling processes, multi-tasking, distraction from the
clinician, and insufficient education and training of staff. To reduce blood specimen labeling
errors, a large academic medical center implemented an innovative technological solution for
specimen labeling that integrates patient identification, physician order, and laboratory specimen
identification through barcode technology that interfaces with the electronic medical record at
the point of care. A failure mode, effects and critical analysis (FMECA) were completed to
assess for system failure points, and to design workflow prior to training staff. Four failure
points were identified and eliminated through workflow adjustments with the new system. Staff
training utilizing simulation highlighted system safety points. This quality improvement process
applied across adult and pediatric acute and critical care units provided dramatic reductions in
blood specimen labeling errors pre/post intervention.

Keywords: specimen labeling, error, failure modes, effects and critical analysis, (FMECA), simulation, wrong
blood in tube (WBIT), patient safety.
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Specimen Labeling Improvement Project: SLIP
Blood specimens are labeled at the time of acquisition in order to identify and match the
specimen, label, and order to the patient. While the labeling process is not new, it is frequently
laden with errors (Brown, Smith, & Sherfy, 2011). Multiple factors contribute to mislabeling
errors, including lax policies, limited technological solutions, multi-tasking/distraction from the
clinician, and insufficient education and training of staff. Technological advances to support
blood specimen labeling are expensive and have not been widely implemented. The potential
consequences of a mislabeled specimen include misdiagnosis, potential miss-transfusion, patient
discomfort in obtaining a new specimen, delays in treatment, and poor utilization of expensive
resources.
Among the most serious labeling errors is wrong blood in tube (WBIT). Mislabeling preblood transfusion specimens, resulting in WBIT, is an international practice issue and well
documented in the literature to be the most common cause of an adverse blood transfusion
reaction (Ansari & Szallasi, 2011). WBIT is usually discovered when a patient’s blood sample is
found to have an ABO/Rh type that does not match the ABO/Rh type in that person’s historic
Blood Bank file. According to the 2011 National Blood Collection and Utilization Survey
Report (2011), hospitals reported 182,000 sample collection errors. Of these errors, 5,747 were
WBIT errors (3.2% of sample collection errors) (2011 NBCUS Report, 2011).
In various settings, a number of process improvement measures have been implemented
in an effort to reduce mislabeling errors specifically for specimens’ utilized pre-blood
transfusion. The most frequently reported interventions to reduce specimen-labeling error are
strict policies (in clinical setting and Blood Bank), education, and two person checks. However,
these interventions have not resulted in the elimination of error. The persistence of error is
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attributed primarily to human factors (Rees, Stevens, Mikelsons, & Darcy, 2012). Those
facilities that have automated the process of patient identification (barcoding) with label printers
at the bedside, integrating physician order entry, have experienced the most significant reduction
in labeling error. Brown et al. (2011) reports a “label error reduction from 103 to 8 per year
(p<.001)” with implementation of barcode technology and bedside printers (p.13).
Consistent with reports of specimen labeling error in the literature, blood specimen
labeling errors are prevalent at one large academic medical center (medical center). Efforts to
reduce mislabeled specimens by means of sharing error data with management have not achieved
desired results. Implementation of strict policies with accountability, education of clinicians,
technology at the point of care, and systems approaches to reduce labeling error is all strategies
supported in the literature (Evanovitch, 2012). A specimen labeling improvement project (SLIP)
was undertaken at the medical center utilizing known strategies for reducing blood specimen
mislabeling with implementation of an innovative point of care specimen collection management
system (SCMS) integrated with a broader laboratory information system (LIS).
Background Knowledge
The setting for this project is a large (700+ bed), non-profit, tertiary/quaternary academic
medical center located on the West Coast, adjacent to medical, nursing and dental schools. The
patient population is diverse and complex. Laboratory tests approximate on average 448,000
tests per month. Blood transfusions approximate 27,000 units of blood per year and each patient
must be typed and cross-matched to receive a unit of blood (Laboratory Medical Director,
personal communication, August 28, 2014). In 2012, an electronic medical record (EMR) was
implemented across the medical center that includes physician order entry (CPOE) and barcode
technology for medication administration. At the time of the EMR rollout, the Laboratory did
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not have an information system that interfaced with the EMR. Integration of laboratory
information was thought to be critical, not only for access to patient laboratory values but also
because all pre-analytic blood specimen processes were manual, requiring paper requisitions and
generic handwritten or centrally printed labels. Subsequently, the Laboratory implemented a
new Laboratory Information System (LIS) with interface to the EMR. Included in the LIS was a
software system providing the ability to integrate a provider order for specimens with patient
identification, as well as specimen label printing at the point of care. Prior to the LIS, Blood
Bank and Laboratory medical directors would send error data to nurse managers, encouraging
them to follow-up with staff on accurate specimen labeling. Initially, senior nurse leaders were
not included in the specimen label error data distribution and therefore, were not aware of the
issue, or the challenges experienced by staff to label specimens correctly.
According to the Federal Drug Administration (FDA) report on Fatalities Following
Blood Collection and Transfusion (2012), the blood supply is safer today than at any time in
history due to advances in donor screening, improved testing, automated data systems, and
changes in transfusion medicine practices (FDA, 2012). Yet, a patient is more likely to have an
adverse blood transfusion reaction related to a mislabeled specimen (WBIT) than a viral
infection (Dzik et al., 2003; Brown, Smith, & Sherfy, 2011). In fiscal year 2012, two of the 65
total transfusion-related deaths reported to the FDA were attributed to labeling errors (FDA,
2012). Institutions that measure their WBIT rates have reported that mislabeled specimens
account for their highest error rate and these errors are most commonly detected in the
laboratory. Type and cross match blood specimens are compared to a patient’s previous
documented blood type to ascertain a match. According to Ansari and Szallasi (2011), the
estimated “raw” WBIT rate published in the literature is 1:2262 samples (p. 298). The reported
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rate of 1:2262 samples is a reduction based on an international study conducted in 2003 reporting
that 1 in every 165 samples was mislabeled (Dzik et al., 2003). Tondon et al. (2010) conducted a
prospective data analysis and found that blood sample labeling errors were due to failure to label
at the bedside or labeling two or more samples at the same time by the same phlebotomist. The
authors proposed a strict policy of rejecting any mislabeled specimen (Tondon, Pandey, Mickey,
& Chaudhary, 2010). This approach does not account for those patients that have not been
previously transfused and therefore may not have a documented blood type for lab to recognize a
mislabeled specimen (WBIT). Vuk et al. (2014) report “silent WBIT cases” are unrecognized
when two donors have the same blood type during cross match (p. 1201). Dzik et al. (2008)
proposed a statistical process control (SPC) method as a means to reduce labeling errors through
use of data control charts. A similar approach was attempted without success at the medical
center.
The PROBE-TM study (2007) attempted to utilize a simple intervention in the form of a
barrier-warning label on blood bags reminding staff to check the patient’s wristband prior to
transfusion. The investigators concluded that this approach did not improve patient
identification but suggested the robust study design could be applied to investigate other
interventions (Murphy et al., 2007). The most promising method for reducing blood sample
labeling errors was reported by Brown et al. (2011) utilizing barcode technology, order
integration and bedside printers. The authors noted a statistically significant reduction in number
of labeling errors, from103 to eight per year (p<.001) (p. 13). Although this technology is
expensive, most medical centers moving to an EMR have either implemented or plan to
implement barcode technology for medication administration. Barcode technology for patient
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identification and bedside printers for specimen labels could significantly reduce WBIT errors
and other blood specimen label errors.
Technology and methods to reduce labeling errors has not caught up to the safety of the
blood itself. Understanding and reducing human factor error in the clinical setting through the
use of education, policy and technology is essential to eliminating labeling error and reducing the
possibility of an ABO incompatible transfusion, which can result in significant morbidity and
mortality. According to Reason (2000), “the basic premise in the system approach is that
humans are fallible and errors are to be expected, even in the best organizations. Errors are seen
as consequences rather than causes, having their origins not so much in the perversity of human
nature as in ‘upstream’ systemic factors” (Reason, 2000, p. 768).
Local Problem
The process for labeling specimens at the medical center following implementation of an
EMR, but prior to the SLIP project, was laborious and carried with it a high risk for error.
Specimen labeling errors occurred with all specimen types. For the purposes of this project, the
focus was specific to blood specimens. A clinician would obtain an order for a blood specimen,
pick up the paper requisition from the printer (mixed in with other requisitions) at the central
station, gather phlebotomy supplies (tubes, needles, tourniquet) and go to the patient room in
order to obtain a blood specimen. Labels were obtained at the central desk (mixed with other
labels) after the specimen was drawn. Distraction, label mix-ups, wrong requisitions, and lack of
proper identification of the patient could all contribute to labeling errors. The Joint
Commission’s number one National Patient Safety Goal for 2014 continues to be “reliably
identify the patient”, “use at least two patient identifiers when collecting blood samples and other
specimens”, and “label containers used for blood and other specimens in the presence of the
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patient” (The Joint Commission, 2014, p. 1). Additionally, in a study at University of
Wisconsin, Rees et al. (2012) found that one frequently occurring specimen labeling error had to
do with obtaining labels from a department printer rather than at the bedside, resulting in staff
picking up labels for the wrong patient. The labeling system at the medical center seemed
designed to ignore the Joint Commission standards and to replicate errors found in another large
academic medical center.
Blood Bank and Laboratory have been acutely aware of specimen labeling errors.
Incident report data reviewed at nurse quality meetings highlighted labeling errors. When the
Chief Nursing Officer became aware of the problem she sent out several memos to all nursing
staff outlining the important steps of labeling correctly. Label error criteria were categorized by
Blood Bank (see Figure 1.0 – Blood Bank Error Criteria).
Figure 1.0. Blood Bank Error Criteria
Category

Errors Included

Near Miss Specimen Errors

1. Wrong Blood in Tube – Usually discovered when a
patient’s sample is found to have an ABO/Rh type that
does not match the ABO/Rh type in that patient’s
historic Blood Bank file.
2. Discrepancy between patient information (name and
MRN) on specimen and requisition.
3. Patient information on specimen is incorrect or missing
4. Patient information on requisition is incorrect or missing
5. Unlabeled

Includes serious specimen errors,
which could potentially lead to issuing
a wrong unit of blood to a patient.
These include the following types of
errors:
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Specimen Collection Problems
Includes other types of specimen
problems, which prevent Blood Bank
from testing a sample. These
specimen problems require the patient
to be drawn again and take up extra
nursing and Blood Bank staff time to
manage.
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1. Unsigned specimens – per AABB Standards (CA law)
Blood Bank must be able to identify the individual who
drew the sample. Thus Blood Bank requires all samples
to have legible name/signature of phlebotomist (or 5
digit MD #).
2. Hemolyzed specimens
3. Phlebotomist signature on tube is illegible
4. Requisition missing
5. Quantity Not Sufficient (QNS)
6. No specimen
7. Wrong tube type
8. Empty tube
9. Other (i.e. date of draw missing, Draw Date/Time the
nd

same for 2 ABO/Rh sample, diluted with saline,
spillage)

(Medical Center Transfusion Medicine, 2012).
In 2013, there were 117 near miss labeling events and 612 collection problems (see Appendices
A and B-Blood Bank Specimen Labeling Errors and Collection Errors 2011-2013).
Unlike Blood Bank, Laboratory blood specimen-labeling error data is not separated into
the same categories (near miss and collection). On average, 88 blood specimen-labeling errors
are noted by Laboratory each month (Communication from Laboratory Medical Director, August
2014) (see Appendix C - Laboratory Specimen Labeling Errors Jan. 2013 to June 2013). Time to
correct an error was estimated at a minimum of one and a half hours (30-40 minutes Laboratory
personnel and one hour for Nursing personnel).
Errors in labeling specimens have never been an accepted practice but the magnitude of
the problem was never fully appreciated until implementation of an EMR and LIS. With WBIT
occurrences increasing, Transfusion Medicine led the way in insisting on improvement measures
in specimen labeling, knowing the risk of a wrong blood transfusion and associated morbidity
and mortality. Additionally, a clinical nurse specialist assigned as a category manager for the
incident report system for blood transfusion alerted senior nursing leadership to the details of the
mislabeling problem, prompting the nursing leadership into action.
Intended Improvement/Purpose of Change
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The goal of this project was to reduce specimen-labeling error by replacing the manual
specimen collection workflow, which included the necessity of printing labels and a paper
requisition for each test at a central station and providing in its place a system for positive patient
identification through barcoding and order matching. Plans had been in place to implement a
SCMS for several years. However, due to limitations in technology, in the Laboratory and prior
to an EMR, the project was placed on hold. The project was re-ignited when the increase in the
medical center’s WBIT errors were brought to light, as patient safety is paramount for the
organization. Implementation of a SCMS is not widespread in health care due to cost and
complexity but has shown impressive results in specimen labeling error reduction (Morrison et
al., 2010).
In 2001, “The Institute of Medicine issued a report, Crossing the Quality Chasm: A New
Health System for the 21st Century, which outlines six overarching “Aims for Improvement” for
health care:
Safe: Avoid injuries to patients from the care that is intended to help them.
Effective: Match care to science; avoid overuse of ineffective care and underuse
of effective care.
Patient-Centered: Honor the individual and respect choice.
Timely: Reduce waiting for both patients and those who give care.
Efficient: Reduce waste.
Equitable: Close racial and ethnic gaps in health status.” (IHI, 2014, p. 1).
Based on the overarching aims for healthcare, the AIM statement for this project is to reduce
specimen-labeling errors in blood specimens drawn in acute and critical care by 50% in nine
months. The new SCMS technology and specimen labeling workflow was piloted on one acute
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care adult unit and one acute care pediatric unit to determine if the technology, workflow, and
education of staff was operational and effective in reducing blood specimen labeling errors.
Review of the Evidence
Prior to implementing an error reduction strategy for specimen labeling, it is important to
examine the evidence nationally and internationally, asking the question “What strategies reduce
blood specimen labeling errors in acute care/critical care settings?” A comprehensive literature
search of PubMed, CINAHL, and EMBASE was conducted, followed by an analysis of the
words contained in the titles and abstracts of the published studies, as well as the index terms
used to describe the article. Reference lists of all studies were searched for additional studies not
previously identified. Only English language studies from 2000 to 2014 were considered for
inclusion. Of note, the literature search did not surface any randomized controlled studies (see
Appendix D – Evidence Table: Specimen Labeling Error).
Cottrell et al. (2013) “conducted a systematic review addressing the issue of WBIT” (p.
197). Nine studies were eligible for inclusion and no randomized controlled trials were eligible
(p. 199). The investigators found the incidence of WBIT was studied extensively, with a finding
of WBIT in 1:1,500 to 1:3,000 samples. After a thorough review, all interventions to reduce
WBIT were successful to some degree and multiple interventions over time were more likely to
sustain a reduction in WBIT, though the duration of the reduction was unclear. Positive patient
identification, “zero tolerance” policies, education, weekly feedback, second check of ID, and
electronic transfusion systems were found to be effective, individually and/or in combination
(Cottrell et al., 2013).
A one-year prospective study conducted by Elhence et al. (2012) in the Department of
Transfusion Medicine at a large tertiary academic medical center in India tracked all near-miss

SPECIMEN LABELING IMPROVEMENT PROJECT: SLIP

15

and adverse events in the transfusion process and found that of the 285 transfusion related
events, 271 (95%) were near-miss events. Of those events, 53% were patient sampling errors,
labeling errors, blood component handling errors, and storage errors. Nine of these errors
resulted in WBIT and were associated with collection of two or more samples from the same
ward (Elhence, Shenoy, Verma, & Sachan, 2012).
An extensive analysis of laboratory event reports in 30 health care organizations studied
by Syndman et al. (2014) found that “pre-analytic laboratory events were the most common
(81%); the top three were specimen not labeled (18.7%), specimen mislabeled (16.3%), and
improper collection (13.2%)” (p. 147). The author further notes that “clinical laboratories
contribute to nearly 23% of all reported errors”, contributing to unnecessary patient harm and
cost (p. 147).
As far back as 2003, Dzik et al. and the Biomedical Excellence for Safer Transfusion
(BEST) Working Party of the International Society for Blood Transfusion were investigating
mislabeled and miss collected blood samples. Eighty-two facilities located in 10 countries
participated in a collaborative three-month study to identify and report mislabeled specimens,
WBIT, and other collection errors. The authors report that the “rate of mislabeled and miss
collected specimens was 1,000 to 10,000 fold more frequent than the risk of a viral infection”
(Dzik et al., 2003, p. 40).
Valenstein et al. (2006) went on to conduct a Q-Probes Study with 120 clinical
laboratories to further understand error rates, adverse patient outcomes, and factors associated
with lower error rates and better detection of errors. The investigators found that identification
errors were common. “Participants from 120 institutions submitted information about a total of
6,705 identification errors. Of these, 5,731 (85%) of errors were detected before results were
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released by the laboratory and 974 (14.5%) were detected after results were released” (p. 1109).
Grimm et al. (2010) conducted a similar study to Valenstein utilizing a Q-Probe analysis of 122
clinical laboratories but focused on mislabeling and WBIT samples. “A total of 112,112 sample
labels were reviewed and 1,258 mislabeled samples were identified for an overall mislabeled
sample rate of 1.12% or 1 in 89 samples” (p. 1114). “The rates of mislabeled samples and WBIT
for United States participants were comparable to those reported in European countries” (p.
1108).
A prospective study by Tondon et al. (2010) conducted at a 740-bed hospital blood center
from January 2007 to June 2008 found error rates similar to those reported in previously noted
studies. Additionally, the Tondon study identified two key circumstances related to mislabeling;
(1) multiple blood samples from same ward, and (2) failure to label at the bedside (p. 311). In
examining root causes for error, the findings regarding WBIT errors occurring when multiple
samples are obtained from one ward were similar to the findings in the study conducted by
Elhence in India.
Dunn and Moga (2010) conducted an extensive qualitative analysis at the Veterans
Health Administration of 227 root cause analysis reports, from March 2000 to March 2008, to
identify vulnerabilities in specimen collection, processing, analysis, and reporting associated
with patient misidentification (p. 244). Their findings prompted the following recommendations
for improved safety and reduced error: Wireless barcode technology at the bedside to confirm
patient identity and to label a specimen immediately with a barcode label; barcode technology
for the blood transfusion process; using of unique patient identifiers; automating laboratory
forms; eliminate re-labeling in laboratory; making centralized phlebotomy continuously
available; and eliminating paper labels in the operating room (p. 255). When these
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recommendations are linked with an updated laboratory information system, the turnaround time
for reporting results is reduced. After implementation of many of this study’s recommendations,
the SLIP team found similar results preliminarily with regard to a reduced turnaround time for
Laboratory at the medical center. Though the study was conducted from 2000 to 2008 and
published in 2010, many of the recommendations are still not in place in most institutions,
demonstrating an unfortunate lag between evidence of best practice and implementation.
Standard quality improvement measures have demonstrated some success in reducing
specimen-labeling errors, although the error rate is not zero. A study by Wagar et al. (2006)
utilized longitudinal statistical tools to analyze and trend patient safety implementation projects.
The study found that 24/7 phlebotomy service, electronic event reporting, and automated
processing contributed to decreased patient identification errors. The investigators also note, that
“Specific elements that contribute to success are sometimes difficult to identify in a longitudinal
analysis schematic”(p. 1668).
Dzik et al. (2008) found that application of a simple statistical process control (SPC) was
a useful tool to monitor critical processes and could be applied to specimen collection and
labeling. The SPC tool was adapted by 10 hospitals across five countries over a two-year period.
A similar SPC tool is utilized at the medical center for tracking with results shared with
managers. The tool is useful for process tracking but has not proven to be effective in reducing
error or changing practice behavior.
Education has been noted in the literature to have a positive impact on reducing specimen
labeling and collection errors. Bolenius et al. (2013) found that phlebotomists had poor
adherence to blood specimen collection guidelines. In that study, phlebotomists were divided
into an intervention group (n=84) (received education) and a control group (n=79). “The
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educational program included three parts: guideline studies, an oral presentation, and an
examination. Improvements were noted in the intervention group after education” (p. 1).
Strict policies whereby blood banks reject any mislabeled specimens or specimens with
error are documented in the literature to be of some success in reducing error. One such study
from O’Neill et al. (2009) supports these findings. In their retrospective study, the investigators
studied the “combined effect of an educational campaign with strict enforcement of a specimenlabeling policy by all clinical laboratories on the incidence of mislabeled and WBIT specimens
detected in blood bank” (p. 165). The intervention demonstrated a 73.5% (0.034% to 0.009%;
p<= .0001) WBIT reduction and an 84.6% (0.026% to 0.004%; P<= .0001) reduction in
mislabeled specimens (p. 164).
The emergency department at the medical center is one of the areas with the greatest
number of mislabeled specimens and WBIT errors. A pre-post intervention study by Hill et al.
(2010) demonstrates that pairing of an electronic physician ordering system combined with
barcode patient identification and barcoded specimen labels in an emergency department does
reduce labeling errors. A 74% relative and 31% absolute decrease in labeling errors was noted
(p. 630). Continued error was attributed to instances where physician order entry and/or barcode
identification was not used. Brown et al. (2011) noted that utilization of this same technology
reduced labeling errors from 103 to 8 per year (p. 1).
A study by Morrison et al. (2010) confirmed positive outcomes with use of a barcode
identification system combined with automated label printing, but found recurrent errors related
to the lack of physician order integration, where paper requisitions were relied upon. Mismatch
of requisitions and blood tubes were the primary errors noted. This is somewhat surprising,
given that the study group encompassed only a small group of phlebotomists. Even when a
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clinician has only one task, human error plays a role. Even more troubling, a study by Snyder et
al. (2010) found that barcode identification systems are not foolproof. Malfunctioning and
poorly maintained barcode printers can introduce error in to the system via erroneous barcode
labels and/or identification wristbands. The investigators strongly recommend industry
standards to address equipment functioning and quality.
Anasari and Szallasi (2011) investigated the use of a two-clinician patient identification
check and a change in nursing policy regarding phlebotomy and found marginal improvement.
The authors did not conduct a statistical analysis of their results. The study further highlights the
need for blood bank to “exhaust all resources in preventing” error (p. 301). In 2006, the
American Association of Blood Banks (AABB) began requiring two “independently drawn”
specimens pre-transfusion for any patient not previously type and cross-matched by a facility (p.
300). In 2009 at their institution, the authors implemented the two-specimen intervention.
Shortly thereafter, phlebotomists began altering the workflow process by drawing two specimens
from a patient at the same time. We have had similar issues at the medical center.
Reduction of human error and diffusion of innovation are concepts highlighted in the
evidence as critical factors in designing an error free system for specimen labeling. A
combination of technology, system design, strict policies and education can reduce error. More
research is needed to obtain zero error rates in blood specimen labeling.
Conceptual/Theoretical Framework
Theoretical and conceptual frameworks provide a guide for translating science into
practice. According to White and Brown (2012) a systematic approach to the translation of new
knowledge into practice, guided by a framework or model, will increase the chances of a
successful implementation (p. 25). A conceptual framework, (The Swiss-Cheese Model of
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Human Error by James Reason) and a theory, (Diffusion of Innovations by Everett Rogers) were
utilized as frameworks for implementation of the innovative point of care specimen labeling
system (SCMS).
In 1990, James Reason, professor of psychology at University of Manchester, proposed
that human error could be approached from a person perspective or a system perspective. The
person approach has historically asserted that errors arose from poor mental processes such as
carelessness, negligence, forgetfulness, inattention and lack of motivation. A systems approach
assumes humans are imperfect and errors will occur but are a consequence of system issues or a
breakdown in “defenses” such as alarms, warning systems and poorly designed processes. The
defenses are equated to layers of Swiss cheese with holes that open and close. A breakdown in
one layer of cheese (hole) would not generally cause a bad outcome but if multiple layers of
cheese holes aligned simultaneously, a major error is likely (Reason, 2000). Reason further
categorizes these breakdowns as two distinct types of failures: active and latent. Active failures
are those errors committed by front-line operators and include such things as not following
policy and procedure, omitting an important step in a process, or ignoring a warning signal.
Latent failures are present in a system before a recognizable error or failure and lie dormant until
a combination of factors ignite their presence. All systems have a certain number of latent
failure points and the goal is not to eliminate all factors but to identify and neutralize. Error can
be introduced into a system at all levels and at any time. According to Reason, “Error proneness
and the capacities for being stressed, failing to perceive hazards, being ignorant of the system,
and having less than ideal motivation are brought by each individual to the workplace” (Reason,
1990, p. 479).

Furthermore, according to Rasmussen (1983), people have three levels of

performance: (1) skill-based errors (action made is not what was intended); (2) rule-based

SPECIMEN LABELING IMPROVEMENT PROJECT: SLIP

21

mistakes (action intended did not achieve intended outcome); and (3) knowledge-based mistakes
(actions are intended but did not achieve outcome due to knowledge deficits) (p. 259).
Understanding Reason’s conceptual framework as it relates to latent failure points in a
system, knowing these latent failure points contribute to the current labeling process error rate,
and incorporating the science of human factors engineering provides a framework for addressing
blood specimen labeling errors at the medical center. The goals of human factors in health care
are to support the health care professional in their work and to promote safe, quality care (Russ et
al., 2013, p. 802). Human factors science is “about designing systems that are resilient to
unanticipated events and modifying the design of the system to better aid people” (Russ et al.,
2013, p. 803) and to address the levels of performance noted by Rasmussen. In addition,
according to Russ et al. (2013) stand-alone trainings are generally a weak intervention, but
designing training programs after evaluating the workflow supports safety. The SLIP project
team took a systems and human factors approach in designing the SCMS implementation. The
team conducted a failure modes, effects, and critical analysis (FMECA) to understand system
vulnerabilities and potential latent failure points. It developed potential strategies to mitigate
identified vulnerabilities while designing simulation training and workflow processes prior to
implementation of the SCMS with staff involvement. The SCMS eliminates at least four failure
points from the current manual labeling process. However, error reduction will only be
accomplished if the new innovative technology is adopted throughout the organization.
Once the implementation plan was developed, the SLIP project team focused on
innovation adoption, best framed through Everett Roger’s (1962) theory on Diffusion of
Innovations. Rogers, a professor of communication studies, theorized that diffusion of an
innovation (perceived as new) occurs through communication channels among members of a
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social system over time. Wide adoption of an innovation must occur in order for the adoption to
self-sustain and there is a point where the rate of adoption reaches a critical mass. Rogers
conceived of five categories of adopters: innovators, early adopters, early majority, late
majority, and laggards” (Rogers, 1962, p. 150). Further, he claimed that each individual
experiences five stages of accepting an innovation: knowledge, persuasion, decision,
implementation, and confirmation. During the decision stage, the individual decides whether to
adopt or reject the innovation. Adoption is an individual process, whereas diffusion is a group
process and social systems determine norms on diffusion. Additionally, certain specific
characteristics of innovations influence adoption: relative advantage, compatibility, complexity
or simplicity, trial ability, and observability (Rogers, 2004).
Implementation of SCMS technology and process were directed toward reconfiguring the
value chain for patients by reducing specimen label errors. The patient is unlikely to notice the
change in process but will benefit from avoiding the necessity of additional phlebotomy due to a
labeling error. Error reduction also saves clinicians time through decreases in follow-up and lab
re-draws, not to mention reduced turnaround time for laboratory test results. Highlighting
benefits to patients and staff encourages adoption to new workflows.
Nurses in acute and critical care were introduced to and trained on SCMS. Unit-based
nursing champions (early adopters) were identified and received additional training on SCMS,
allowing them to support their peers with the new technology and process and to communicate
any issues to the project team. This approach is a cultural norm and has been used successfully
in numerous large initiatives at the medical center. Simulation training (highly regarded) and
staff involvement with the FMECA and project planning contributed to effective communication
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about the new process and its optimization. The sole competitor was the previous paper-based
process known by all clinicians.
Methods
Ethical Issues
The goal of the SLIP project was to implement a quality improvement process and meet
the University of San Francisco’s (USF) definition of quality improvement (as defined by The
Institute of Medicine): “a systematic pattern of actions that is constantly optimizing productivity,
communication, and value within an organization in order to achieve the aim of measuring the
attributes, properties, and characteristics of a product/service in the context of the expectations
and needs of customers and users of that product” (USF DNP Department Policy, 2014, p.9). On
September 23, 2013 USF determined that the project met the guidelines for an Evidence-based
Change in Practice Project as outlined in the Doctor of Nursing Practice Project Checklist (see
Appendix –E- Student Project Approval: Statement of Determination). There are no identifiable
ethical issues or conflicts of interest noted for this project.
Setting
The SLIP project was conducted at a 700+ bed academic medical center on the West
Coast. The medical center is known for providing care to patients with highly complex medical
and surgical diagnoses. The academic medical center is undergoing a major transformation as
evidenced by a new vision, name, and newly developed strategic plan (2014-2019) that will
guide the organization in delivering on their mission. Implementation of an innovation in
specimen labeling, which enhances safety and care delivery, is consistent with mission, vision
and values and strategic plan of the organization. The medical center’s vision is to provide
innovative, high-quality, cost-competitive clinical services, and to deliver unparalleled patient
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experience across the entire continuum. Strategic goals, being a leader in destination programs,
promoting a high valued system, and achieving a culture of continuous process improvement all
further define how the organization will live its mission. Utilizing these directional strategies
provides stakeholders with their purpose and alignment.
For acute care patients, phlebotomists work with specimens obtained from a direct stick
to the patient. Registered nurses (RN) obtain all blood specimens in critical care and line draws
in acute care. Prior to implementation of the SCMS, acute care staff labeled their specimens
after collecting the specimen and critical care staff labeled beforehand. Phlebotomy is not a core
skill for RNs and has been loosely coupled with the Laboratory. Blood specimen labeling errors,
primarily an issue with RN phlebotomy, had been identified by the medical director of Blood
Bank and the medical director of Laboratory as a serious safety issue over several years. The
director’s approach of sharing data with managers proved ineffective in reducing blood specimen
labeling errors. Senior nursing leaders did not fully appreciate the issue at the time.
Implementation of an EMR further highlighted the problem. Potential for error abounded with
mismatched specimen labels, requisitions and patients. Systemic issues could not be corrected at
the local level. Subsequent implementation of a LIS for Laboratory provided the necessary
software and integration of systems for utilizing technology to address the specimen labeling
issue.
Planning the Intervention
Plans were developed for implementation of the SCMS to integrate order entry with
patient identification and specimen labeling at the point of care (see Appendix – F – SCMS
Concept). Initially, SCMS was to roll out across all inpatient settings and in the Emergency
Department at the medical center. However, having identified complexities of SCMS early on,

SPECIMEN LABELING IMPROVEMENT PROJECT: SLIP

25

the SLIP project team determined that a smaller scale implementation would yield a higher rate
of success and that further implementation of SCMS could be accomplished at a later time. The
goal of this project was to reduce specimen label errors by replacing the existing manual
specimen collection workflow with an innovative, integrated technology, SCMS. Patient safety
is a primary objective of the medical center and implementing a new collection management
system for blood specimens addresses the need for improved workflow and reduced labeling
errors.
Objectives
1. Utilize current barcode scanning equipment and EMR for SCMS;
2. Train staff on SCMS processes by utilizing a simulation training approach;
3. Implement SCMS on two pilot units, with spread to adult/pediatric acute and critical care
units.
Initially, SCMS was to roll out across all inpatient settings and emergency department at the
medical center. However, having identified complexities of the SCMS early on, the SLIP project
team determined that a smaller scale implementation would yield a higher rate of success and
further implementation of SCMS could be accomplished at a later time. Emergency Department,
Mother/Baby, and Perioperative Services all have higher labeling error rates than acute and
critical care and also have dissimilar and complex workflows that need further analysis prior to
SCMS implementation.
Laboratory purchased 150 wireless label printers in anticipation of implementing SCMS.
As part of the EMR plan the medical center had already installed barcode scanners at every
inpatient bedside for medication administration along with a computer workstation. An early
version of label printers had been tested on a handful of units several years prior and failed
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miserably. At the time, there was no EMR with order integration and barcode scanners had not
been installed. Achieving a better result required thoughtful planning. This project was multifaceted and required a significant amount of support from IT, dedicated time to conduct a
FMECA and streamline workflow, resources to educate/train staff, and time for policy revisions.
A nurse informatics project manager and Laboratory Services manager, was assigned to
the SLIP project as well as an information technology (IT) project manager. These three leaders
coordinated logistics and drove the project. The Associate Chief Nursing Officer
(ACNO)/Doctor of Nursing Practice (DNP) student took administrative lead of the project and
partnered with the Patient Safety manager. The Chief Nursing Officer (CNO)/Executive
Director of Patient Care Services covered executive sponsorship. The Chief Medical Officer
offered, as a resource, a GE Six Sigma/Lean consultant to assist with data management and to
provide structure using six sigma and Lean tools. A staff nurse was added to the SLIP team.
Staff involvement is a key to success in most of our projects, as staff brings valuable insight to
workflows and processes that are not apparent to those not practicing at the bedside. An
educator was assigned to develop simulation scenarios and assist with initial training. The listed
roles comprised the core SLIP team. Additional stakeholders, including staff were included on
an ad hoc basis (see Appendix – G – Stakeholder, Role, Responsibility and Communication
Matrix).
Effective communication was essential with a project of this magnitude both with the
project team as well as with external customers such as clinicians, providers, and managers. A
weekly project team meeting was held to review deliverables, issues, changes, risks and
decisions. Development of a SharePoint site facilitated daily updates and communication within
the team. Unit-based super-users provided local staff support.
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The ACNO/DNP student explored the literature for evidence-based approaches to
correcting specimen labeling errors and to better understand the problem on a global level.
Evidence in the literature indicates that the SCMS approach has achieved the best results in
reducing specimen-labeling errors. Focus and commitment from Laboratory, Blood Bank, IT,
and executive leadership provided a platform for success in moving forward with this project.
Staff has embraced bedside technology and historically, when they are included in project
planning/implementation, they have engaged in supporting project success.
A business case was compiled to determine the best option going forward.
Options
Option #1 Maintain Current System: The specimen labeling system was paper-based and
did not interface with the EMR. Specimen labels were printed at a central station in batches.
Nurses would obtain laboratory requisitions from one printer at the central station and labels
from another printer. There were many opportunities for mismatching labels, requisitions and
specimens. Patient identification at the point of care for obtaining specimens was inconsistent.
The medical center has approximately 50-100 (88 average) specimen labeling errors per month
in Laboratory and another 88/month in Blood Bank at a cost of $125.00 each. Patient safety is
compromised with potential for a life-threatening event due to a mislabeled specimen or WBIT.
Laboratory turnaround times are slowed down when error occurs and clinician time is increased
due to the need to address an error.
Option #2 The Preferred Solution: Implement SCMS across the adult, pediatric acute
and critical care areas. SCMS integrates patient identification, provider order, and laboratory
specimen identification through barcode technology and interfaces with the EMR at the point of
care. Nurses will use this technology as a safer process for specimen labeling.
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Option #3 Alternative: Implement SCMS on a limited basis to selected inpatient areas.
Training costs account for a large portion of the expense of this project. Limiting the areas
where SCMS is utilized reduces training costs. However, two standards of specimen labeling
would exist, potentially leading to confusion, inconsistency, and non-standard workflows for
nurses, phlebotomists, and laboratory technicians processing specimens in the laboratory.
Standard specimen labeling processes with integration in the EMR reduces opportunity for error.
A cost/benefit analysis of the three options was completed (see Appendix–H- Cost/Benefit
Analysis). Maintaining the current labeling process was the most expensive option, noting that
every error could result in a potential lawsuit. Options #1 and #3 did not meet the objectives of
improving safety and reducing error. Option #2 cost had an equal benefit within a year,
primarily due to cost avoidance. An even greater benefit noted if multiple lawsuits were
avoided.
The project team’s decision, supported by the executive sponsor and Laboratory
collaborative sponsors, to move forward with Option #2 in a phased approach: acute and critical
care (adults and pediatrics) phase one, Emergency Department and Mother/Baby in phase two,
and Perioperative Services and Respiratory Therapy in phase three. One adult and one pediatric
acute care unit piloted the new SCMS for one month to assess for workflow issues, equipment
issues and to optimize processes prior to further rollout. A project charter was developed by the
SLIP team to further define the project scope and deliverables (see Appendix – I – Project
Charter).
The SLIP team (plus ad hoc group) conducted a FMECA from January to March 2014
prior to finalizing education and simulation training as a proactive risk assessment to determine
failure modes in the specimen labeling process using SCMS as a new system. Identified
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vulnerabilities would be mitigated, if possible, prior to implementation. The FMECA was
presented to Patient Safety Committee and approved. An education plan was developed that
included training unit-based super-users for local support of staff and trouble shooting issues, as
well as training pilot unit staff in SCMS. Initially, the plan for education had been a one-hour
classroom training. However, that quickly evolved (after FMECA results) to a two-hour
simulation training, including a module on specimen labeling errors and a video showcasing the
path of a specimen through the Laboratory (See Appendix –J- Training Module). In addition,
further investigation of safe practices by a staff member of the SLIP team uncovered a process
called Final Check that verbalizes a final check of the last three digits of the medical record
number. All involved in the FMECA supported incorporating Final Check into the SCMS
process.
“In May of 2011, Palmetto Health Richland Hospital in Columbia, South Carolina and
the South Carolina Hospital Association partnered with Outcome Engenuity in a project
to demonstrate a rapid reduction in the number of mislabeled blood specimens. The goal
was to achieve a 90% drop in mislabeled specimens (the wrong patient’s label on a blood
specimen) in a 90-day time frame. The project was intended to be a broader
demonstration of the power of Just Culture concepts to dramatically reduce the rate of
adverse patient safety events. The project was met with immediate success at Palmetto
Health. As a second phase, the South Carolina Hospital Association recruited five
additional hospitals to implement The Final Check in an attempt to validate its
universality. As with Palmetto Health Richland, five additional hospitals showed a 90%
reduction in mislabeled specimens in the first month after implementation, improving to a
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93% reduction after three months. The success has been sustained for five months thus
far, as of June 2012” (Final Check, n.d., p. 1).
Implementation of the Project
Back-end IT infrastructure to support implementation of SCMS was performed in 2012
and was part of a separate capital budget project. Barcode scanners were installed with EMR
implementation in 2012. Equipment installation for SCMS began in January of 2014 by
Facilities and IT. This entailed installation of brackets to hold label printers, mobile carts, and
testing of wireless connectivity with the label printers. Connectivity issues were immediately
identified; IT attempted to remedy, but without success. The Informatics nurse determined that
an adaptive approach was needed. Cables were purchased to wire the wireless label printers to
in-room computers. Acute care units have fewer laboratory orders requiring nurse phlebotomy;
therefore, each acute care unit has three or four portable label printers to use with specimen
collection. The SLIP project training for super-users and staff (pilot units) began in March,
conducted by an educator and project managers from Informatics and Laboratory. Education
was well received. Staff commented that they felt prepared to use SCMS on their units and had a
better understanding of specimen management and the importance of labeling correctly. Process
compliance monitoring began immediately, with data collected by Laboratory and observation
from nurse managers. The SLIP team was interested in whether staff were using the new system
or continuing to use the old paper-based system. Observations revealed staff was using the new
Final Check process in addition to the labeling system. Over the course of the pilot month,
compliance rose to 90% as more staff was trained on pilot units. Workflows were adjusted
based on staff feedback and new discoveries with the SCMS functionality. After a successful
pilot series, further training and rollout of SCMS occurred across all of the acute care units,
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following the same optimized model. A workflow assessment of critical care was conducted and
simulation training adjusted accordingly. Critical care staff was trained and SCMS implemented.
Compliance monitoring was incorporated. A draft specimen labeling policy/procedure was
written with input from SLIP team members, Laboratory medical director, and reviewed by staff
to ensure the document reflected practice (See Appendix –K- Specimen Labeling Policy).
Feedback from staff and Laboratory was evaluated to determine if there were further
training needs and/or equipment and workflow issues had surfaced. Super-users provided onsite
unit support to staff and were able to answer numerous questions. IT intervened on equipment
issues. The staff nurse working with the SLIP team provided training for staff returning from
leave of absence and those new to the organization. Training for new hires will be incorporated
into new hire orientation.
Planning the Study of the Intervention
Regular debriefing on project implementation was essential to assessing a successful
implementation and to inform improvements for phases two and three. An overall approach of
Plan, Do, Study, Act (PDSA) drove the project through to completion in phase one and will be
used for subsequent phases. The project began in October 2013 with an initial meeting of key
stakeholders from the project team, Laboratory, Blood Bank, IT, Facilities, Performance
Improvement, and Nursing Education. In November 2013, the design was completed and later
enhanced after the FMECA was completed. Training began in March with the pilot units
utilizing SCMS by April 2014. (See Appendices L and M- Gantt Chart and Training and
Implementation on SCMS). Numerous improvements were made on the pilot units prior to
broader rollout. As an example, labeled specimen tubes began arriving in the Laboratory with
labels that were offline. Laboratory personnel were convinced the nursing staff was mislabeling.
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However, on investigation, the team discovered that the labels were not properly inserted in the
label printers. Loading labels into printers was incorporated into training.
Staff was asked to complete a Survey Monkey to provide feedback on satisfaction with
the new system and training, as well as to report any challenges. One comment nicely sums up
the system “when all the technical aspects are functioning properly, it is a highly efficient
process. The workflow does take some getting used to, however, once settled, it’s safe and quick
and I can use my time for other patient concerns” (See Appendix –N- Survey Monkey Tool).
Laboratory and Blood Bank continued to send specimen labeling error data. The SLIP team
extracted the units using SCMS to determine improvements/error reduction. The Laboratory
manager involved in the project provided feedback from the Laboratory’s perspective. The
FMECA process informed educational planning for simulation training (workflows and potential
failure points) and identified equipment adjustments required prior to implementation. Steps in
the FMECA process included:
•

Steps in the process of using SCMS (bedside procedure or handheld portable Dolphin)

•

Potential failure modes

•

Potential causes of failure

•

Effects of the failure

•

Ranking severity, probability of failure effect and detection

•

Calculating criticality to rank order potential failure modes and prioritize remedial efforts

•

Potential solutions and outcome measures

(See Appendices – O and P– Failure Mode, Effects and Critical Analysis (FMECA) Summary
and Workflow Analysis).
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Project details were carried out by the IT project manager, Informatics nurse and
Laboratory manager, all with strong project management skills. Installation of brackets, ordering
additional label printers, cables and labels, and assisting the educator with staff training
comprised some of their project duties. Facilities, Clinical Engineering, and IT ensured
equipment was ready for use across 15 units. Once the equipment was in place, training and
follow-up were key items going forward, with approximately 1800 nurses to be trained. Nurse
managers were accountable for staff following the new labeling process. The ACNO/DNP
student granted approval for financial resources to order equipment and find rooms for training
when the simulation lab was unavailable. The Patient Safety Manager and ACNO/DNP student
co-presented the project to the Patient Safety Committee and other interdisciplinary forums to
communicate the change process.
Primary objectives were achieved and the organization gained valuable insights about the
risks associated with specimen collection and labeling. Timeline challenges were ongoing.
Labor disputes and competing priorities necessitated adjusting schedules. Discussions of
risks/benefits of delaying training and/or implementation were frequent and acknowledged that
the primary desired outcome was a robust, accurate labeling process. Baseline data
demonstrated the need for improvement (See Appendices – A, B and C - Blood Bank Specimen
Labeling Errors and Laboratory Specimen Labeling Errors 2011-2013).
Methods of Evaluation
Instruments used for evaluation were multifactorial. Laboratory specimen labeling error
data collection was in place prior to SCMS implementation and continued after implementation.
The GE consultant collaborated with Performance Improvement to extract from the data set
those units using SCMS to measure improvement. The LIS vendor-developed Survey Monkey

SPECIMEN LABELING IMPROVEMENT PROJECT: SLIP

34

to staff, collected information on satisfaction and challenges with the training and process (See
Appendix –N - Survey Monkey). An observation tool developed by the SLIP staff nurse
representative provided a mechanism for observing practice and measuring process (See
Appendix – Q-Observation Tool). Measurement of staff compliance with using SCMS is tracked
through a manual process in the Laboratory and provided to the GE consultant for analysis.
Other metrics and data analysis for specimen labeling are still in development. Patient days were
used for a denominator to determine labeling error rates. In September, new software installed in
Laboratory will enable counting of samples (denominator). Further discussion with Performance
Improvement is necessary in order to determine ongoing process measures, frequency of
measurement, and reporting structures. Only labeling error measurements were provided by
Laboratory prior to SCMS.
A strengths, weaknesses, opportunities and threats analysis (SWOT) was used to
determine risk and feasibility of this project (see Appendix – R – SWOT Analysis). Resources
are stretched for IT-related projects, which must compete with EMR updates, optimization,
report requests, and the ongoing construction of a new facility at a new campus location.
However, laboratory orders touch every patient and any error poses significant risk for adverse
outcomes.
Project expenses and return on investment (ROI) were determined in a financial analysis
compiled by the ACNO/DNP student. Budget for SCMS implementation consisted primarily of
training expense, with an estimated 3,644 hours (2 hours/nurse x 1,527 nurses). Staff backfill
time was unnecessary, as other staff on duty could provide care delivery during training. Staff
direct-labor expense was calculated at $65.00/hour and indirect labor expense at 30%, totaling
$85.50/hour. Licensing and acquisition of SCMS software occurred through Laboratory and was
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integrated into the EMR by IT through a separate capital expenditure. Additional expenses
incurred included funds for printers, cables, power strips, and wiring. Project managers, GE
consultant, and educator were included in budget projections. The nurse’s home unit absorbed
staff nurse participation time on the SLIP team. Project sponsors were not included as expenses,
given that this type of project is a portion of their daily work. ROI occurs after 48 months based
on an assumption that labeling errors are eliminated and cost avoidance produces a savings.
SCMS does not generate revenue. Further cost avoidance from lawsuits are possible but not
captured in budget projections (see Appendix – S – Budgetary Return on Investment Plan
(ROI)).
SCMS implementation in critical care surfaced workflow issues not apparent in acute
care. Volume of laboratory orders, physician practices in critical care and EMR design imposed
unexpected challenges. A critical care focus group of staff, IT, and Laboratory was designated to
meet weekly and work through and resolve issues. Avoiding development of a workflow
breakdown was paramount to quickly resolving workflow problems.
Analysis
Both quantitative and qualitative data were collected from participants to evaluate
process, satisfaction, error rates, and problems with the new system. Survey Monkey software
was used for an online survey and Laboratory information system was used to note labeling
errors and Laboratory turnaround time. Patient days were used as a proxy denominator for
number of specimen samples. Data analysis is a work in progress with the SLIP project. More
time is needed to trend data and hardwire new processes and workflows, continually monitoring
for unintended latent failure points.
Results
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Program Evaluation/Outcomes
The medical center is a complex, somewhat chaotic organization, that despite
environmental and system challenges, delivers extraordinary care. Standardization of processes
has not been emphasized historically. Leadership realizes the lack of standardization creates a
vulnerability. The evidence in the literature is clear: standardization enhances patient safety. In
addition, once the medical center as a whole is aware of a safety issue, there is an impetus to
correct the problem. Therefore, over the past several years, the focus has been on setting in place
standard processes and workflows. Reason’s work makes it apparent that any system will have
latent failure points that need to be recognized and monitored. Lack of standard workflows
creates difficulty in tracking failure points.
Staff response to SCMS has, for the most part, been positive. Equipment and EMR
workflows are continually under revision and are the greatest sources of complaint. As a result
of feedback on inconsistent equipment and supply availability, the Unit Coordinators were
enlisted to conduct daily checks of necessary items (See Appendix – T –Unit Coordinator
Checklist). The Laboratory Medical Director and Blood Bank Medical Director are both pleased
and anxious for SCMS to be implemented across the organization. Senior leadership is impatient
with project length, had to be reminded of previous decisions that slowed progress. Quality
leaders desire full implementation as soon as possible.
As with many projects, no one had any idea the magnitude this project would entail in
terms of length, required resources, and impact prior to the FMECA and phase one
implementation. Initially, the idea was to use existing technology (barcode scanners and bedside
computers), then add label printers at the bedside to improve patient identification and specimen
labeling. During the course of the project, questions arose regarding EMR workflow and
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Laboratory interface in general, but those were not within the scope of this project. The initial
improvement plan evolved over time, as previously noted, driven by several factors, including
new knowledge (FMECA), labor disputes (slowed timeline), IT connectivity (slowed timeline),
adjustment in required equipment (wireless label printers an adaptive model), competing
priorities for project managers, and competition for training space. The SLIP team and medical
center leadership mitigated all of these challenges for phase one. The enthusiasm of all
participants was of great help in moving the project forward, as was team communications to
others in the organization. The simulation training provided a positive and informative
approach, not only regarding SCMS but also in regard to human factors error. Development of a
process audit plan with a schedule for all units and managers is still needed and is under
consideration.
Despite numerous challenges, implementation of SCMS has been dramatically successful
in reducing blood specimen labeling errors, although compliance with using the system is
currently at approximately 50%. Once fully implemented across the medical center, it will
represent a significant step toward ensuring patient safety. Early results are positive. As noted,
more data collection and analysis is needed (See Appendices U, V, W, X and Y – Training
Compliance, Efficacy of SCMS with Blood Bank, Efficacy of SCMS with Lab, Laboratory
Labeling Errors After SCMS, and Laboratory Reported Labeling Errors). Laboratory turnaround
time data is not presented due to the need for further analysis. Pressure is mounting to complete
phases two and three of SLIP, which will include Emergency Department, Mother-Baby and
Perioperative areas. However, the medical center is preparing for a new campus and facility;
resources are stretched. The SLIP team recommended to senior leadership of Laboratory and
Nursing to wait on phase two and three until the campus transition is complete. Risks of waiting
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include ongoing safety issues with specimen labeling in high-risk areas and the possibility that
the project will not reinvigorate for phase two and three. The benefits of waiting include an
opportunity to re-focus, ability to study workflows in complex settings before implementing, and
time to install equipment with testing prior to implementation. Leadership made the final
decision to wait until the new campus transition was complete. In the meantime, the medical
director of Laboratory and members of the SLIP team will contact other organizations that have
implemented SCMS and use the same EMR, to exchange information. The team hopes to glean
insight for those issues identified in phase one and to better prepare for phase two and three
implementation.
Discussion
Summary
Implementation of SCMS was successful for several reasons: (1) the system and process
reduced RN time for specimen collection; (2) it provided a streamlined workflow; (3) it
improved safety for patients; (4) it led to a reduction in both labeling error and Laboratory turnaround time (preliminary data). Two factors contributing to the success of implementation were:
(1) conducting a FMECA to understand workflows and failure points prior to education
programming, and (2) incorporating staff on the SLIP team and in workgroups. Role-play
simulation training was somewhat new for the medical center. It has proven to be a powerful
tool in demonstrating to staff the full scope of a process, highlighting potential failure points and
providing feedback to staff after return demonstrations. Role-play simulation training was
utilized with barcode medication administration; data analysis shows a 95% barcode compliance
rate for patient identification and medication identification. Translating medication
administration processes to blood specimen collection processes may have contributed to early
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success. Unit-based super-users have been, and continue to be with this project, successful
models for the medical center, supporting staff when they need it. Ongoing leadership will be
necessary to sustain error-labeling reductions, including regular review of data at quality
meetings. Holding staff accountable to use SCMS is another critical factor. In an emergency,
paper requisitions may be used for blood specimens. Unfortunately, some staff has continued to
use paper requisitions in non-emergent situations. Laboratory is considering increased
restrictions and will not accept paper requisitions for non-emergent specimens. Development of
a process audit plan with a schedule for all units and managers is necessary and will be
developed in the next month.
Advanced practice nurses prepared in systems thinking, integrated with quality and
performance, are essential for projects such as SLIP. The gap between evidence and practice
continues, but as more nurses are prepared in advanced roles, that gap should narrow. It is
unclear whether the project managers would have facilitated a FMECA or enhanced simulation
training without influence of the ACNO/DNP student and Patient Safety Manager. Further, this
project highlights the need for flexibility from the micro to macro levels.
Relation to Other Evidence
The SLIP project results appear to be similar to findings from other organizations that
implemented a SCMS type system. Results are not directly comparable; the sample denominator
is needed from Laboratory. However, internal pre/post improvement is evident and comparable.
Other organizations report strict processes and policies, but also note potential breakdown in
workflow processes. Observation and direct feedback to staff after implementation are
interventions known to improve processes and outcomes. The SLIP team is committed to
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conducting periodic observations and following up with managers to ensure hardwiring of the
new system.
Barrier to Implementation/Limitations
Studying the SCMS process uncovered issues with connectivity and equipment,
physician orders, workflow and integration with Laboratory processes. A few issues were
anticipated and a few were not anticipated. Some of these workflow issues have impact on RNs,
particularly in critical care, and are under investigation for improvement solutions. Equipment
functionality has been the biggest concern for acute care, specifically regarding wireless printers
that did not have adequate and consistent connectivity. An adaptive model was implemented.
RNs obtained a label printer from a central unit location and then plugged the printer into the
computer in the patient room. Ports have become worn and damaged with plugging and
unplugging. Further investigation of alternatives for an adaptive model is underway.
Sometimes when an organization has a heavy focus on outcome data, the process to
achieve those outcomes may cover other issues that might thwart safety. An example is the
expectation to use barcode medication administration. The SLIP team found that the nurse
determination to use a barcode scanner potentially introduces error. If the barcode scanner is not
functioning properly at the patient bedside and troubleshooting does not result in a functioning
scanner, the nurse is likely to go to another room to use that scanner. When identification and
labeling do not occur at the point of care, safety is compromised. Greater focus on equipment
maintenance was an outcome of this project.
The greatest challenge for the SLIP project team has been resources to train (including
space limitations), progression to implementation, data analysis, and full evaluation. Although
this project was a collaborative effort between Nursing and Laboratory, most of the project has
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been led by Nursing. This makes sense for training and unit implementation, but not necessarily
in terms of accountability for data analysis and accountability for ongoing resources to
disseminate SCMS across the medical center. Unforeseen labor disputes and IT issues disrupted
original timelines and these changes had a consequence to the project, as resources were pulled
to other planned implementations. Competing priorities are a known operational balancing act.
Phase two and three will be implemented at a later date.
Interpretation
Units that have implemented SCMS have reduced levels of specimen labeling errors.
Standardizing workflow, identifying patients, integrating physician orders electronically through
the EMR, and labeling specimens at the point of care all contributed to reducing errors in
specimen labeling. While eliminating breakdowns in system processes and maintaining strict
adherence to policies is difficult, both are essential to sustaining improvement. Regular
measurement and data presentation, holding leaders accountable for outcomes, and gathering
feedback from nurses regarding barriers to improvement will all support sustaining the gain.
Until there is accurate sample data (denominator), comparable data to outside organizations is
forthcoming. Pre/post results are dramatic but trending is needed. The SLIP team expected
significant improvement but knew that until all staff had been trained on SCMS and was using
the system, data would not reflect the full impact of SCMS. Discontinuation of paper
requisitions is needed to force function staff to use SCMS.
Improvement projects such as SLIP are equivalent to peeling an onion with many layers.
The project team acknowledges that until a workflow analysis is completed for any given area, it
is nearly impossible to anticipate failure points. Phase two and three units have high volume
Laboratory orders and complex workflows. The experience of completing phase one SCMS,
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informed the decision to study workflows in phase two and phase three areas prior to
implementation. Other opportunities for improvement with Laboratory specimen ordering and
collection have surfaced. Though they were not within scope for this project, they have been
brought to the attention of and key leaders. As mentioned previously, SLIP team members and
Laboratory medical director will be contacting other organizations for their expertise.
Conclusions
Systems approaches and technology, combined with human factor science, are absolutely
necessary for error reduction and patient safety. Unfortunately, equipment manufacturers and
organizations often do not incorporate these strategies to reduce error and the burden is left to
those directly delivering care to patients. In addition, a change in one system impacts other
systems and produces unanticipated consequences. Thoughtful plans, resources,
implementation, and evaluation are necessary for success. If appropriate quality measures are
not instituted on the front end of a project, the time to course correct after implementation is
large. Specifically, more research is needed regarding what, on the surface; seem to be
straightforward processes, such as labeling a specimen. Implementation of SCMS has reduced
specimen-labeling errors and will be more broadly installed in coming months. Even with the
new system and technology, error is not eliminated nor does it approximate six-sigma. The
medical center is moving toward technology as a strategy to improve systems, reduce
redundancy, improve safety and improve efficiency. A systematic review of each service
interface would likely highlight those processes needing improvement, which is preferable to
waiting for an untoward event to surface the problem.
Other Information
Funding
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Funding for the SLIP project occurred over several years (implementation of EMR, barcode
scanners, LIS), under capital funding. One hundred fifty wireless label printers were purchased
by Laboratory. Additional equipment, installation needs, and staff time to participate and be
trained in the project was absorbed into Nursing Administration cost center. Nursing maintains
project and discretionary funds for projects that are not fully funded or need support.
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Appendix C
Laboratory Specimen Labeling Errors January 2013 to June 2013

Mislabeled and Unlabeled Samples by Unit 1/13-6/13
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Appendix D
Evidence Table: Specimen Labeling Error

STUDY

METHOD

SAMPLE

INTERVENTION

OUTCOMES /
RECOMMENDATIONS

STRENGTH
OF
EVIDENCE
I-V

QUALITY
OF
EVIDENCE
A-C

III

C

Anasari &
Szallasi
2011

Retrospective
qualitative
study

N=59,373
(26 WBIT)

Incidence of wrong blood in
tube (WBIT) over 4 years

(WBIT) represents leading
cause of potential mistransfusions. Two specimens
and policy impact some
labeling errors but more safety
measures needed

Bolenius et
al.
2013

Quasiexperimental
study

N=84
N=79

Pre/post questionnaire after
education

Some improvement but not
significant

II

B

Brown et al.
2011

Pre/post
intervention
study

N=103
errors/yr

Decrease from 103 labeling
errors to 8/year (p<.001)

III

B

Dunn &
Moga
2010

Qualitative
study

Pre-analytic phase errors
accounted for 182 out of 253
patient misidentification errors

III

B

Hospitals in 10 countries
reported mislabeled and miscollected sample data

Study concludes mislabeled
and mis-collected samples rate
is 1000-10,000 (1 in 165
samples) more frequent than
risk of viral infection from
blood

III

B

Participating hospitals found
the SPC tool helpful in
monitoring specimen labeling
error reduction progress

III

B

53% were near miss events
that occurred at bedside

III

B

III

B

III

B

III

A

N=227 root
cause analysis
reports
N=71
hospitals
completed
questionnaires
N=62
hospitals
submitted data
N=690,000
samples

Implementation of specimen
collection/labeling system
with barcode technology and
label printers
Qualitative analysis of 227
root cause analysis reports
from Veterans Health Admin.

Dzik et al.
2003

Qualitative
study

Dzik et al.
2008

Nonexperimental
longitudinal
study

10 hospitals in
5 countries

Applied statistical process
control charts tabulating the
frequency of mislabeled and
mis-collected blood samples
over 2 years

Elhence et
al.
2012

Nonexperimental
longitudinal
study

N=285
transfusion
related events
from 2009 to
2010

Prospective study in India to
record, classify and analyze
near miss and adverse events

Prospective
study

N=122
institutions

Each institution reviewed inpt
and outpt ABO samples for
labeling errors

Prospective
observational
study

N=28 nurses,
16 techs, 17
ED assoc.

Simulated patient scenarios
with eye-tracking device

Hill et al.
2010

Pre/post
intervention
study

Pre
N=724,465
Post
N=334,039

Physician order entry and
barcode id

Kim et al.
2012

Retrospective
analysis
study

N=9072

Standardized process-driven
id and specimen labeling
protocol

Decrease of 5.79 events/1000
to 3.53/1000

III

C

Morrison et
al.
2010

Pre/post
intervention
study

Pre
N=181,758
Post
N=184,043
specimens

Barcode patient identification
and label printers, training

43% reduction in mislabeled
samples
38% reduction in unlabeled
samples

III

A

O’Neill et
al. 2009

Pre/post
intervention
study

Education and strict policy
adherence

73.5% reduction in WBIT
errors
(0.034% to 0.009%; p<.0001)

III

B

Grimm et
al.
2010
Henneman
et al.
2010

Pre
N=106,174
Post
N=104,860
specimens

All institutions combined had a
mislabeled sample rate of
1.12%
Wide variation among health
care workers in verifying
patient id
Combination of Physician
order entry and barcode reduce
Emergency Dept. specimen
labeling errors (31%) with 95%
confidence
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STRENGTH
OF
EVIDENCE
I-V

QUALITY
OF
EVIDENCE
A-C

STUDY

METHOD

SAMPLE

INTERVENTION

Rees et al.
2012

Pre/post
intervention

N=197
specimen
identification
events

Post interventions an 85% error
reduction in specimen label
errors

III

C

Snyder et
al.
2010

Quasiexperimental
study

As many as 3 incorrect patient
identifiers generated from
single defective barcode

II

B

Snydman et
al.
2012

Qualitative
study

Cross-sectional analysis of 30
organizations of reported
laboratory events in US

Pre-analytic laboratory events
were the most common
(81.1%)

III

B

Tondon et
al.
2010

Prospective
study

Prospective study to report
distribution, type and
frequency of errors through
blood bank

Total of 342 errors (6.2/1000
samples) with 87.1% clerical
and 86.5% outside of blood
bank

III

B

Valenstein
et al. 2006

Q-probes
analysis
study
Nonexperimental
longitudinal
study

N=10
defective
barcodes
N=225
scans/barcode
N=37,532
laboratory
event reports
from 30 health
care orgs
N=32,189
recipient
samples
N=22,794
donor samples
N=120
institutions

Four areas of focus;
establishing clear
expectations of staff,
education, process (system)
review and feedback
Re-scans conducted by 3
operators, 15 times each,
using 5 different scanner
models

Compilation of lab patient id
errors over 120 institutions

Most errors are detected before
results released (85%)

III

B

Longitudinal study of WBIT
frequency in donor samples in
Croatia

WBIT error rate was 34
(0.0018%). Potential causes
multifactorial and controllable

III

B

24/7 phlebotomy service,
electronic event recording,
automated processing

Implementation of patient
safety measures reduces
specimen-labeling errors. 1230
total errors/month reduced to
555/month

III

B

Vuk et al.
2014

Wagar et al.
2006

Nonexperimental
longitudinal
study

N=955,218
blood
donations
collected over
12 year study
period (20022013)
N=16,632
total specimen
errors
2003-2005

Level 1 = Experimental study/randomized controlled trial (RCT) or meta-analysis of RCT
Level II = Quasi-experimental study
Level III = Non-experimental study, qualitative study, or meta-synthesis
Level IV = Opinion of nationally recognized experts based on research evidence or expert consensus panel (systematic
review, clinical practice guidelines)
Level V = Opinion of individual expert based on non-research evidence. (Includes case studies; literature review;
organizational experience eg. Quality improvement and financial data; clinical expertise, or personal experience)
A = High Research—consistent results with sufficient sample size
Summative Reviews—well-defined, reproducible search strategies
Organizational—well-defined methods using a rigorous approach
Expert Opinion—Expertise has been clearly evident
B = Good Research—reasonably consistent results, sufficient sample size
Summative Reviews—reasonably thorough and appropriate search
Organizational—well-defined methods
Expert Opinion—expertise has been clearly evident
C = Low Quality or Major Flaws Research—little evidence with inconsistent results, insufficient sample
Summative Reviews—undefined, or poorly defined methods
Organizational—adequate reliability or validity
Expert Opinion—expertise has not been discernable
Newhouse, R., Dearholt, S., Poe, S., Pugh, LC., White, K., Johns Hopkins Evidence-Based Practice Appraisal.
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Appendix E
Student Project Approval: Statement of Determination

University of San Francisco
School of Nursing and Health Professions
Student Project Approval:
Statement of Determination
Title of Project: Develop a strategy to reduce pre-transfusion blood specimen labeling errors at the point of
care in a hospital setting.

Brief Description of Project: Pre-transfusion blood sample labeling errors increase the risk of transfusionassociated patient morbidity and mortality and continue to be a significant risk in hospital settings in the US
and internationally. According to the literature, pre-transfusion blood specimen labeling errors present a
greater risk than the safety of the blood and error reduction may be reduced through education, policies, and
barcode technology.
Baseline error data will be collected including blood transfusion specimen label errors and wrong blood in
tube errors (WBIT) across all inpatient units. Utilizing process mapping to understand current process,
review of current policies, and thorough literature review for evidence based practices, and introduction of
barcode technology as an improvement strategy. Lean methodologies will be utilized to reduce process waste
and engage staff in process improvement solutions.
Post improvement data will be collected on a unit-by-unit basis and a root cause review of each error as a
means to further understand and improve the process.

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the criteria outlined in
federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)

X This project meets the guidelines for an Evidence-based Change in Practice Project as outlined in the Project
Checklist (attached). Student may proceed with implementation.
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This project involves research with human subjects and must be submitted for IRB approval before project
activity can commence.
Comments:

Signature of Supervising Faculty__________

(date)

Signature of Student

(date)

EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
STUDENT NAME:

Traci Hoiting

DATE: September 23, 2013 .

SUPERVISING FACULTY: K T Waxman.

Instructions: Answer YES or NO to each of the following statements:
Project Title:
The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There is
no intention of using the data for research purposes.
The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive standard of care.
The project is NOT designed to follow a research design, e.g., hypothesis testing
or group comparison, randomization, control groups, prospective comparison
groups, cross-sectional, case control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves implementation of established and tested quality standards
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT
develop paradigms or untested methods or new untested standards.
The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.
The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.
The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.
The agency or clinical practice unit agrees that this is a project that will be
implemented to improve the process or delivery of care, i.e., not a personal
research project that is dependent upon the voluntary participation of colleagues,
students and/ or patients.
If there is an intent to, or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: “This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board.”

YES

NO

X
X
X

X

X

X
X
X

X
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ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an Evidence-based
activity that does NOT meet the definition of research. IRB review is not required. Keep a copy of this checklist
in your files. If the answer to ANY of these questions is NO, you must submit for IRB approval.
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human Research
Committee, Partners Health System, Boston, MA.

THIS TABLE PROVIDES AN OVERVIEW OF THE DIFFERENCE BETWEEN RESEARCH AND QUALITY
OR PROCESS IMPROVEMENT
RESEARCH
“A systematic investigation, including
research development, testing and
evaluation, designed to develop or
contribute to generalizable knowledge.
Activities, which meet this definition,
constitute research for purposes of this
policy, whether or not they are
conducted or supported under a
program, which is considered research
for other purposes. For example, some
demonstration and service programs
may include research activities.”
http://www.hhs.gov/ohrp/humansubject
s/guidance/45cfr46.html#46.102

QI/PROCESS IMPROVEMENT
Assess or improve a process, program or
system to improve performance as judged
by the evidence, i.e., established/ accepted
standards

PURPOSE

Answer a question or test a hypothesis

Improve performance/ process or systems

BENEFITS

May or may not benefit current
patients, but may benefit future patients

Directly benefits a process, program or
system and may or may not directly benefit
patients

RISKS

May put subjects at risk

Does not increase risk to patients with
exception of possible privacy/
confidentiality concerns

DATA
COLLECTION
DATA
ANALYSIS

Systematic data collection

Systematic data collection

Statistically prove or disprove
hypothesis

Compare a program/ process/ system to an
established set of standards

DEFINITION
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Appendix F
SCMS Concept

SCMS


DesignPoints
State of the Art Technology

Product concept
TargetCustomer(s)
NursingStaff

UseCases
Safety:Patient,laborder,specimen
identification
Regulatory:Labelatpointofcare
Efficiency:Nopaperrequisitions

Product
Pointofcarespecimenlabeling
technology

ProblemstoBeSolved
•

PortableEquipment

•

Interfaceswith
ElectronicMedical
Record

•

BarcodeTechnology

•

Interfaceswith

LaboratorySystem
•

PointofCare
Technology

•

ReducesErrors


Customer Benefits
Functional: Equipment, specimen tubes, laboratory
order, labels, and patient identification all in one
place
Emotional: The organization cares about my
patients and me
Social: Safety for Patient-Centered Care

Labelingerrorsduetomislabeled
specimensandmisidentifiedpatients
Decentralizedspecimencollection
process
Multiplestepstoassemblesupplies
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Appendix G
Stakeholder, Role, Responsibility and Communication Matrix
Stakeholder
CNO

Role
Executive
Sponsor

Medical Directors,
Laboratory and
Transfusion
Medicine
ACNO/DNP
Student

Collaborative
Oversight of
SLIP Project
Project SponsorNursing

Patient Safety
Manager

Project SponsorPatient Safety

Informatics Nurse

Project LeadNursing

Laboratory
Services Manager

Project LeadLaboratory
Services
IT Systems
Management

Information
Technology
Project Manager
GE Consultant

Staff Nurse

Educator

GE Six
Sigma/Lean
Consultant
Project
Assistance

Simulation
Educator

Responsibilities
Approves budget,
resources, point of
escalation for issues that
can’t be resolved within
SLIP team
Removing barriers during
project implementation

Communication
Communication to senior
executives on project
progression/issues

Approves scope, FMEA
co-lead, training time,
budget for training,
escalation of issues
FMEA co-lead, chairs
SLIP project team,
represents Quality
Management Team
Purchase of equipment,
coordinator of project, and
training, super-user
competency sign-off
Laboratory Services
configuration, training,
SCMS expert
Coordinate all IT
interfaces, SCMS vendor
interface and wiring
Incorporating Lean and Six
Sigma concepts into
project, data analysis
Policy review, workflow
review, training,
observation survey
development, general
troubleshooting
Development of simulation
scenarios and training

Communication to
Nursing
Directors/Managers

Communication to
Medical Staff Quality
Committees

Liaison to Quality
Management and Patient
Safety
Project Update
Communication

Liaison to Laboratory
Management Leadership
Liaison to IT Leadership

Liaison to Performance
Improvement
Liaison to Staff and
within SLIP Team

Liaison with Nursing
Excellence
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Appendix H
Cost/Benefit Analysis
Cost/Benefit Analysis
Category

Details

Option # 1
No change

Cost of error correction: Personnel
time=$125/error x 729 errors (1 year,
2013)
Cost of potential lawsuit: $500,000
(history of 1 lawsuit related to mislabeled
specimen)

Total
Option # 2
Phased
approach
Total
Option # 3
Only complete
Phase 1
Total

Phase 1 equipment and training acute
care/CC care (adults and peds)
Phase 2 and 3 ED, Mother-Baby, Periop
Only do Phase 1

Cost in First
Year
$91,125 cost of
errors: BB &
Lab
$500,000 cost
of one lawsuit
$591,125
$354,563
$ 100,000
$454,563
$354,563
$354,563

Benefits
Benefit
Avoid potential lawsuit related to specimen labeling

50% reduction in specimen labeling errors in 9 months
(personnel time)
Patient satisfaction
Total
Potential Expense if Each Error Resulted in a Lawsuit

Benefit Within
12 Months
$500,000 x 1
($500,000 x
729 actual
errors =
$364,500,000)
potential
expense from
lawsuits
$45,563.00
$50,000
$595,563
($364,595,562)
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Appendix I
Specimen Labeling Improvement Project Charter

•

Project Objective
Reduce specimen labeling error by
replacing current manual specimen
collection workflow including the necessity
to print a paper requisition for each test and
labels at a central station and to provide
positive patient identification with barcoded
patient identification and order matching to
enhance specimen collection processes.

Deliverables

•
•
•
•

Technical go-live for pilot unit: 03/01/14
Pilot go-live for 2 nursing units: 03/31/14
FMEA: January to March 2014
Additional unit go-live: TBD

•

Training materials reflect continuity from
Computer Provider Order Entry (CPOE)
order entry to SCMS Registered Nurse (RN)
workflow using computers, scanning
devices, and specimen label printers
Completion of training is mandatory for
inpatient RN staff

•

Scope
In Scope:
• Phase 1: Inpatient Nursing Units
(adults/pediatrics)
• Phase 2: ED and Mother/Baby
• Phase 3: Perioperative areas,
Respiratory Therapy collected
specimens,
• Lab Tests: All order types, blood
specimens for clinical lab/Blood
Bank
Out of Scope:
• Special procedural areas,
Outpatient locations, non-blood
specimens
Information Technology
•

•
•
•

Procurement/deployment of
wireless and wired label specimen
printers to patient care areas
Customer Service Support
provided by IT
Backend infrastructure built and
supported by IT
SCMS application deployed to all
patient care computers

Success Criteria
•
•

•

Utilization by end-users 70% after
one month
Patient identification with
barcoding and order matching
>90% after one month
Mislabel reduction by 50% after
nine months for acute/critical care
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Appendix J
SLIP Training Module
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Appendix K
Specimen Labeling Policy
Office of Origin:
I.

Department of Patient Safety

PURPOSE
To enhance patient safety by providing a consistent method for correct
identification of inpatient and outpatient specimens.

II.

REFERENCES
The Joint Commission National Patient Safety Goals
The Joint Commission Laboratory Accreditation Manual, Standard
QC.2.20 Laboratory Manual for MEDICAL CENTER Clinical
Laboratories
Administrative policy 2.1.1 Patient Identification
Department of Pathology Specimen Receipt, Identification, and Rejection Policy

III.

DEFINITIONS
Not applicable.

IV.

POLICY
For all specimens taken from patients for clinical testing or received in a
laboratory setting from within or outside of Medical Center, the person
collecting or receiving the specimen must verify the correct specimen and
correct patient by comparing two unique identifiers to one or more source
documents, such as the order for the lab test, or other appropriate paperwork,
and labels for the specimen.
The two identifiers are the patient’s name and medical record number. If for
some reason the specimen must be/has been collected before a patient has been
registered or if the specimen is from a source outside of Medical Center, the
patient’s name and birth date may be used as the patient identifiers.
This policy applies whether a specimen is sent to the laboratory for processing
or is used for a point-of-care laboratory test.

V.

PROCEDURES
A. Collecting specimens
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1. Refer to the MEDICAL CENTER and MEDICAL CENTER
SATELLITE Clinical Laboratories Manual, the MEDICAL CENTER
Pont- of-Care Testing Manual, and department-specific procedures for
test-specific information related to how to collect and send a specimen.
2. Prior to obtaining the specimen, assure proper patient identification by
comparing two patient identifiers provided by the patient or from the
patient ID wristband (inpatient) per Patient Identification
Administrative Policy 2.1.1 to the order(s) or paper requisition(s). If
using a manual process (e.g. a system other than Specimen Collection
Management System) assure printed specimen labels match two patient
identifiers and the patient information on the requisition. For
specimens, such as urine, stool, sputum, collected by the patient, apply
an addressograph/Epic patient label to the specimen container prior to
giving it to the patient. Departments using Specimen Collection
Management System will attach a Specimen Collection Management
System generated label to the container after the specimen has been
obtained.
3. If the order or paperwork (labels and paper requisition) and one or more
of the identifiers do not match, do not collect the specimen. Obtain
correct patient or correct paperwork and repeat patient verification
process. If unable to verify, notify the appropriate provider who
ordered the test.
B. Labeling Specimens

1. For specimens being sent to the main Clinical Laboratory using a
requisition it must include, at a minimum, the following:
ii.

patient’s first and last name

iii.

patient’s sex and date of birth

iv.

Medical Record number

v.

patient location

vi.

ordering physician name and identification number (ambulatory patients)

vii.

applicable ICD-9 code(s) (ambulatory patients)

viii.

tests to be performed

2. For specimens being sent to Pathology, the requisition must contain:
ii.

Patient’s first and last name

iii.

Medical record number and/or birth date

iv.

Location (hospital, clinic, private office)

v.

Date specimen obtained from patient

vi.

Attending/referring physician name

vii.

Specimen source/site
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viii.

Pre-op diagnosis, ICD-code, or relevant history

3. Specimen label:
i.

For Clinical Laboratory specimens labeled using Specimen
Collection Management System labels are generated after
collection of specimens and include patient first and last name,
medical record number, date of birth, date collected, time
collected and phlebotomist code and test to be run.

ii.

Specimens collected without Specimen Collection
Management System MUST at a minimum include patient first
and last name, medical record number or date of birth and date
collected.
1) For Clinical Laboratory samples, when preprinted labels from
the Clinical Labs or Specimen Collection Management System
are not available, use an addressograph/Epic label, or legibly print
the patient’s first and last name, MEDICAL CENTER medical
record number or date of birth and date and time of collection.
2) For Clinical Laboratory specimens collected for Blood Bank
tests, including blood typing, and/or cross match, the
addressograph/Epic label must include patient's full name,
medical record number, date of birth, date/time drawn and person
collecting sample information (written legibly) name (first and last)
or code or if collected by a physician, physician ID number and
name (first and last). Initials are NOT accepted.
3) For Pathology specimens, the site/source must be included if
multiple sites are involved, in addition to name, medical
record number and/or date of birth.

4. Label every specimen obtained in the room or at the bedside of the
patient except when the specimen is collected by the patient himself,
such as urine or stool. In this case, label the container with an
addressograph/Epic patient ID label prior to giving it to the patient.
Departments using Specimen Collection Management System will
attach a Specimen Collection Management System generated label to
the container after the specimen has been obtained.
5. Place only specimen(s) and any paperwork from only ONE patient in a
bag for transport to the laboratory. Ensure that specimen(s) and
paperwork in the bag are from the same patient.
C. Labeling Specimens Removed During A Surgical Procedure

1. The specimen label includes the patient identification information, the
specimen source identification, and any other information required by
laboratory policy.
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2. Specimens are properly labeled in the room where they are collected;
such sites include operating rooms, examination and treatment rooms
in ambulatory practices, and any other area where specimens are
obtained.
3. For pathology specimens, the patient identification label should be
affixed to the side of the specimen container, and not on the lid if at
all possible.
D. Receipt of Mislabeled and Unlabeled Specimens

1. When the identification of a specimen submitted for analysis is in
any way questionable, the laboratory will recommend that, if
feasible, a new specimen should be obtained.
2. If the laboratory is unable to determine from whom a specimen
has been collected with a reasonable degree of certainty, a new
specimen must be obtained.
3. When there is a mismatch between the name on any paperwork and on
the specimen (Mislabel) the specimen should in virtually all
circumstances be recollected. In cases where a mislabeled specimen is
irretrievable or where re- collection would jeopardize patient care (e.g.
invasively collected samples, intra- operative samples, timed samples,
etc.) AND the specimen itself can be identified with reasonable
certainly, exceptions to the above policy may be made. These decisions
will be the responsibility of the Laboratory Medicine resident on duty or
a Laboratory Director. In cases where the mislabeled specimen is
approved for testing, the patient's physician must accept responsibility in
writing for the specimen being processed. The test result in the patient's
chart will carry the notation the sample was "REC'D
MIS(UN)LABELED-RUN AT MD'S REQUEST and under some
circumstances an entry may be made in the progress notes by laboratory
staff further describing the relevant circumstances.
4. The pathology department will make every effort to obtain the
information needed to process the specimen; however, if they
prove unsuccessful, the specimen will not be processed.
VI.

RESPONSIBILITY
Questions about the implementation of this policy under routine circumstances
should be directed to Patient Safety Department 555-1212.

VII.

HISTORY OF POLICY
Separated from Patient Identification policy, April
2002 Approved April 2002 by CEO
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Revised July 2005 by Director, Regulatory Affairs Reviewed
September 2005 by Policy Steering Committee
Reviewed by Patient Care Director, Ambulatory Care Services
Approved November 2005 by Executive Medical Board, Governance
Advisory Committee
Reviewed by Lab Standards Committee, January
2010 Reviewed by Patient Safety Committee,
February 2010 Reviewed by Policy Steering
Committee, March 2010 Reviewed by Senior
Leadership Group, March 2010 Reviewed by
Patient Safety Committee May 2010
Revised by Patient Safety Manager July 2014
Reviewed by Patient Safety Committee July 2014
Reviewed and approved by Policy Steering Committee September 2014

This guideline is intended for use by Medical Center staff and personnel and no
representations or warranties are made for outside use. Not for outside production or
publication without permission.
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Appendix L
Gantt Chart
Milestones

2013
Oct

Initial

2014
Nov

Dec Jan

Feb Mar

Apr

May Jun Jul

10/1

Meeting
Design
FMECA
Training

11/10
1/6
3/1

Acute

CC

Pilot

Care

Unit

Units Units
Implement

3/30

Acute

CC

Pilot

Care

Unit

Units Units
Evaluation
Phases 2
& 3 TBD

4/1

Aug Sept
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Appendix M
Training and Implementation Schedule on SCMS
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Appendix N
Survey Monkey Tool
Initial Report
Last Modified: 06/17/2014
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Appendix O
Failure Mode, Effect, and Criticality Analysis (FMECA) Summary
Failure Mode, Effect, and Criticality Analysis (FMECA) – 2014
Specimen Labeling Improvement Project Summary Report
Aim: During the process of blood specimen collection, errors in ordering, collection and
labeling might occur that could potentially have adverse patient consequences. This FMECA
was done as a proactive risk assessment prior to initiation of SCMS, a new process for specimen
labeling and requisitioning of a specimen order, to determine failure modes in the specimen
labeling process using SCMS identify potential solutions.
Team Lead: ACNO/DNP Student and Patient Safety Manager
Team: SLIP and Ad Hoc
Process: The team met from January 2014 – March 2014 to complete the FMECA prior to
initiation of training for SCMS. SCMS is a LIS application that is used to identify patients and
print labels, which serve the dual purpose of label and requisition, at the patient’s bedside to
eliminate the risk of specimen mislabeling and streamline specimen collection workflow. The
process used to complete the FMECA was to identify:
•
•
•
•
•
•
•

Steps in the process of using SCMS (bedside procedure or dolphin)
Potential failure modes
Potential causes of failure
Effects of the failure
Ranking severity, probability of failure effect and detection
Calculating criticality to rank order potential failure modes and effects importance
Potential solutions and outcome measures

The FMECA was completed prior to initiation of training of super users and pilot unit staff that
began the end of March.
Failure Modes/Potential Vulnerabilities:
Staff may not understand significance of proper technique, potential for error, risk of harm
Solutions:
a) Include pictures of specimens with improperly positioned labels
b) Show how labels are read by machine
c) Include stories from bedside about impact of mislabeled specimens
d) Include discussion of cognitive bias as potential source of error
There are a variety of references used by staff to determine what specimen container to use and
the volume of specimen needed
Solutions:
a) Get rid of all reference material
b) Add specimen container and volume criteria to EMR work list
c) Encourage use of lab manual for infrequently obtained specimens
d) Pediatric units will need reference sheets as lab criteria defaults to adult references
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Hunting and gathering of supplies adds distractions and time to specimen collection process
Solutions:
a) Standardize caddies
b) Develop checklist for managers on assuring equipment is available
There is a potential for equipment to not be available when needed which may result in staff
defaulting to manual process
Solutions:
a) Establish standard work on maintenance of equipment and supplies
b) Develop TIP sheets and FAQs about maintenance of printers and cables
c) Encourage use of dedicated WOW for acute care units
d) Encourage dedicated location for equipment/supplies on all units
Equipment may not work properly
Solutions:
a) Develop troubleshooting guide
b) Encourage managers to develop process for maintaining equipment and supplies
There is a potential for staff to default to process steps that increase the risk for labeling error
Solutions:
a) Establish standard work to include
1. Drawing specimen then labeling
2. The person obtaining specimen is the person who creates label, or if not possible the
person who obtains specimen prints name on label
3. Final check of last 3 digits of MRN said out loud
4. Limit the number of labels at the bedside
5. Develop SCMS Procedure
6. Develop RN blood draw policy
Adoption of SCMS may be slow because it is a new workflow
Solutions:
a) Develop tip sheet for process, have accessible
b) Develop reports on compliance with using SCMS vs. opting out for unit managers

Appendix P
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Workflow Analysis

 The collection process was mapped in entirely and details
 Too manual and paper work driven and dependent
 Printing one place and use the labels in another place
 Loose labels are floating around
 Human Errors
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Appendix Q
Specimen Labeling Improvement Observation Tool

Medical Center
Specimen Collection Management System

Specimen Collection Observation Form
Location:______________________________ Date:____________________________
Name of Person Conducting Observation:______________________________________

Action
1

Requisition Printed (where, when, by whom?):

2

Label Obtained (where, when, by whom?):

3

Supplies Gathered (where, when?):

4

Hand Hygiene: (where, when?, should be more than once):

5

Identifies pt* (should compare name and MRN on armband to req):

6

Assesses venipuncture site (tourniquet applied):

7

Site preparation (cleansing technique):

8

Aseptic technique during venipuncture:
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9

Needle entry angle (between 15-30o):

10

Draw Order (note order in which tube colors/types are drawn):

11

Tubes filled and mixed (how full?, how mixed?):

12

Needle care (safety device used, straight to sharps container?):

13

Bandage applied (how, what):

14

Labels applied:

15

Second Pt ID*:

16

Specimen Handling (which bag, how sent to lab?)

89

Additional
Notes:_______________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
*Tip for patient identification: the current practice does not promote verbalizing this step. Therefore it
is sometimes difficult to ascertain compliance while observing. It is often helpful after the observation to
ask how and what the RN checked for patient ID. With medication observations, the answer is often name
and birthdate, not MRN.
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Appendix R
SWOT Analysis

Strengths
•

Weaknesses

Excellent compliance with barcode

•

Medical center wireless capacity

scanning technology used for patient

•

Workflow change, requiring large

identification with medication

•

scale educational support

administration

•

Competing medical center priorities

EMR with CPOE since 2012-integrates

•

Clinician recognition of error

with SCMS
•

Evidenced-based technology for specimen

impact
•

Additional equipment to maintain,
clean and track

label error reduction
•

Supports and in alignment with medical
center’s strategic plan to improve patient
safety
Opportunities

Threats

Improve patient safety by reducing blood

•

IT system downtime

specimen label error rates

•

Clinician/phlebotomist adoption

•

Improve patient value chain

•

Training expense

•

Reduce Laboratory turn-around time

•

Equipment failure, tracking and

•

Improve clinician satisfaction

•

Reduce waste and inefficiencies, leaving
more time for care delivery

•

cleaning
•

New technology may introduce new
latent failures

•

Failure of previous label printers
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Appendix S
Budget Return on Investment Plan (ROI)

Total
Responses Mean
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Appendix T
Unit Coordinator Checklist

Unit Coordinator SCMS rounding list:
In Patient Rooms:
Cables present
Cable works (plug printer in; if power = then cable intact)
Check that Lab Coll is active (simple icon check)
In Med/Supply Room:
Labels stocked
Label levels in printer adequate
Clean printers, inside and out
Power cables present and working
Monitor open tickets
Place tickets for IT issues found during rounds
General IT fix-its:
• Dead Wow: plug in wow; open back door on bottom; flip black switch; wait 30
seconds; flip switch back)
• Broken Scanner: check that bottom of scanner is tight
White USB cable missing: look for black USB cable!
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Appendix U
Compliance and Utilization Analysis of SCMS
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Appendix V
Efficacy of New Process in Blood Bank
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Appendix W
Efficacy of New Process in Laboratory
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Appendix X
Laboratory Label Errors After SCMS
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Appendix Y
Laboratory Reported Label Errors After SCMS
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